Antineoplastic agents (Румыния - Тендер #45825095)

1. Section I
   1. Name and addresses
      SPITALUL CLINIC C.F. CLUJ
      Strada: Republicii, nr. 18
      Cluj-Napoca
      400015
      Romania
      Telephone: +40 264598278
      E-mail: achizitii_sucf@yahoo.com
      Fax: +40 264598278
      
   2. Joint procurement
      
   3. Communication
      The procurement documents are available for unrestricted and full direct access, free of charge, at
      https://e-licitatie.ro/pub/notices/c-notice/v2/view/100170221
      Additional information can be obtained from the abovementioned addressto the abovementioned address
      
   4. Type of the contracting authority:
      Body governed by public law
      
   5. Main activity:
      Health
      
2. Section II
   1. Scope of the procurement:
      1. Title:
         

         ACORD CADRU ANTINEOPLAZICE 2

         Reference number: 4288349_2023_PAAPD1432975
         
      2. Main CPV code:
         33652100
         
      3. Type of contract:
         Supplies
         
      4. Short description:
         

         Medicamente antineoplazice 2. A se vedea Caietul de sarcini.Autoritatea contractanta va raspunde in mod clar si complet

         tuturor solicitarilor de clarificare/informatiilor suplimentare in a 12-a zi inainte de termenul limita stabilit pentru depunerea

         ofertelor, Nr zile pana la care se pot solicita clarificari inainte de data de depunere a ofertelor este 20

      5. Estimated total value:
         Value excluding VAT: 26 176 836.48 RON
         
      6. Information about lots:
         maximum number of lots: 30
         
   2. Description
      1. Title:
         

         5-Fluorouracilum - flac. 1000 mg

         Lot No: 1
         
      2. Additional CPV code(s):
         33652100
         
      3. Place of performance:
         Main site or place of performance:

         FARMACIE

      4. Description of the procurement:
         

         ANTINEOPLAZICE 2

      5. Award criteria:
         
      6. Estimated value:
         Value excluding VAT: 2 584.80 RON
         
      7. Duration of the contract, framework agreement or dynamic purchasing system:
         Duration in months: 24
         This contract is subject to renewal: no
         
      8. Information about the limits on the number of candidates to be invited:
         
      9. Information about variants:
         Variants will be accepted: no
         
      10. Information about options:
          Options: no
      11. Information about electronic catalogues:
          
          
      12. Information about European Union funds:
          The procurement is related to a project and/or programme financed by European Union funds: no
      13. Additional information:
          
      14. Title:
          

          Irinotecanum - fl.300 mg

          Lot No: 19
          
      15. Additional CPV code(s):
          33652100
          
      16. Place of performance:
          Main site or place of performance:

          FARMACIE

      17. Description of the procurement:
          

          ANTINEOPLAZICE

      18. Award criteria:
          
      19. Estimated value:
          Value excluding VAT: 261 192.00 RON
          
      20. Duration of the contract, framework agreement or dynamic purchasing system:
          Duration in months: 24
          This contract is subject to renewal: no
          
      21. Information about the limits on the number of candidates to be invited:
          
      22. Information about variants:
          Variants will be accepted: no
          
      23. Information about options:
          Options: no
      24. Information about electronic catalogues:
          
          
      25. Information about European Union funds:
          The procurement is related to a project and/or programme financed by European Union funds: no
      26. Additional information:
          
      27. Title:
          

          Nivolumabum - conc.pt.sol .perf.fl 10mg/ml 1 fl.din sticlă x 100 mg

          Lot No: 21
          
      28. Additional CPV code(s):
          33652100
          
      29. Place of performance:
          Main site or place of performance:

          FARMACIE

      30. Description of the procurement:
          

          ANTINEOPLAZICE

      31. Award criteria:
          
      32. Estimated value:
          Value excluding VAT: 11 977 128.00 RON
          
      33. Duration of the contract, framework agreement or dynamic purchasing system:
          Duration in months: 24
          This contract is subject to renewal: no
          
      34. Information about the limits on the number of candidates to be invited:
          
      35. Information about variants:
          Variants will be accepted: no
          
      36. Information about options:
          Options: no
      37. Information about electronic catalogues:
          
          
      38. Information about European Union funds:
          The procurement is related to a project and/or programme financed by European Union funds: no
      39. Additional information:
          
      40. Title:
          

          Etopozidum- fl. 100mg

          Lot No: 14
          
      41. Additional CPV code(s):
          33652100
          
      42. Place of performance:
          Main site or place of performance:

          FARMACIE

      43. Description of the procurement:
          

          ANTINEOPLAZICE 2

      44. Award criteria:
          
      45. Estimated value:
          Value excluding VAT: 4 760.40 RON
          
      46. Duration of the contract, framework agreement or dynamic purchasing system:
          Duration in months: 24
          This contract is subject to renewal: no
          
      47. Information about the limits on the number of candidates to be invited:
          
      48. Information about variants:
          Variants will be accepted: no
          
      49. Information about options:
          Options: no
      50. Information about electronic catalogues:
          
          
      51. Information about European Union funds:
          The procurement is related to a project and/or programme financed by European Union funds: no
      52. Additional information:
          
      53. Title:
          

          Carboplatinum - fl.150 mg

          Lot No: 30
          
      54. Additional CPV code(s):
          33652100
          
      55. Place of performance:
          Main site or place of performance:

          FARMACIE

      56. Description of the procurement:
          

          ANTINEOPLAZICE 2

      57. Award criteria:
          
      58. Estimated value:
          Value excluding VAT: 11 660.40 RON
          
      59. Duration of the contract, framework agreement or dynamic purchasing system:
          Duration in months: 24
          This contract is subject to renewal: no
          
      60. Information about the limits on the number of candidates to be invited:
          
      61. Information about variants:
          Variants will be accepted: no
          
      62. Information about options:
          Options: no
      63. Information about electronic catalogues:
          
          
      64. Information about European Union funds:
          The procurement is related to a project and/or programme financed by European Union funds: no
      65. Additional information:
          
      66. Title:
          

          Docetaxelum - conc.pt.sol.perf., fl. 160 mg

          Lot No: 11
          
      67. Additional CPV code(s):
          33652100
          
      68. Place of performance:
          Main site or place of performance:

          FARMACIE

      69. Description of the procurement:
          

          ANTINEOPLAZICE 2

      70. Award criteria:
          
      71. Estimated value:
          Value excluding VAT: 42 598.80 RON
          
      72. Duration of the contract, framework agreement or dynamic purchasing system:
          Duration in months: 24
          This contract is subject to renewal: no
          
      73. Information about the limits on the number of candidates to be invited:
          
      74. Information about variants:
          Variants will be accepted: no
          
      75. Information about options:
          Options: no
      76. Information about electronic catalogues:
          
          
      77. Information about European Union funds:
          The procurement is related to a project and/or programme financed by European Union funds: no
      78. Additional information:
          
      79. Title:
          

          Epirubicinum - sol.inj/perf, fl. 100 mg

          Lot No: 13
          
      80. Additional CPV code(s):
          33652100
          
      81. Place of performance:
          Main site or place of performance:

          FARMACIE

      82. Description of the procurement:
          

          ANTINEOPLAZICE 2

      83. Award criteria:
          
      84. Estimated value:
          Value excluding VAT: 46 944.00 RON
          
      85. Duration of the contract, framework agreement or dynamic purchasing system:
          Duration in months: 24
          This contract is subject to renewal: no
          
      86. Information about the limits on the number of candidates to be invited:
          
      87. Information about variants:
          Variants will be accepted: no
          
      88. Information about options:
          Options: no
      89. Information about electronic catalogues:
          
          
      90. Information about European Union funds:
          The procurement is related to a project and/or programme financed by European Union funds: no
      91. Additional information:
          
      92. Title:
          

          Acidum zolendronicum - fl.4 mg - 100 ml

          Lot No: 2
          
      93. Additional CPV code(s):
          33652100
          
      94. Place of performance:
          Main site or place of performance:

          FARMACIE

      95. Description of the procurement:
          

          ANTINEOPLAZICE 2

      96. Award criteria:
          
      97. Estimated value:
          Value excluding VAT: 25 104.00 RON
          
      98. Duration of the contract, framework agreement or dynamic purchasing system:
          Duration in months: 24
          This contract is subject to renewal: no
          
      99. Information about the limits on the number of candidates to be invited:
          
      100. Information about variants:
           Variants will be accepted: no
           
      101. Information about options:
           Options: no
      102. Information about electronic catalogues:
           
           
      103. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      104. Additional information:
           
      105. Title:
           

           Cisplatinum - fl. 25 mg

           Lot No: 8
           
      106. Additional CPV code(s):
           33652100
           
      107. Place of performance:
           Main site or place of performance:

           FARMACIE

      108. Description of the procurement:
           

           ANTINEOPLAZICE 2

      109. Award criteria:
           
      110. Estimated value:
           Value excluding VAT: 2 498.40 RON
           
      111. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 24
           This contract is subject to renewal: no
           
      112. Information about the limits on the number of candidates to be invited:
           
      113. Information about variants:
           Variants will be accepted: no
           
      114. Information about options:
           Options: no
      115. Information about electronic catalogues:
           
           
      116. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      117. Additional information:
           
      118. Title:
           

           Ipilibumabum - conc.pt.sol .perf.fl 5mg/ml x 10ml

           Lot No: 18
           
      119. Additional CPV code(s):
           33652100
           
      120. Place of performance:
           Main site or place of performance:

           FARMACIE

      121. Description of the procurement:
           

           ANTINEOPLAZICE

      122. Award criteria:
           
      123. Estimated value:
           Value excluding VAT: 1 535 517.60 RON
           
      124. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 24
           This contract is subject to renewal: no
           
      125. Information about the limits on the number of candidates to be invited:
           
      126. Information about variants:
           Variants will be accepted: no
           
      127. Information about options:
           Options: no
      128. Information about electronic catalogues:
           
           
      129. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      130. Additional information:
           
      131. Title:
           

           Ramucirumabum - fl.10mg/ml fl. x 10ml

           Lot No: 27
           
      132. Additional CPV code(s):
           33652100
           
      133. Place of performance:
           Main site or place of performance:

           FARMACIE

      134. Description of the procurement:
           

           ANTINEOPLAZICE

      135. Award criteria:
           
      136. Estimated value:
           Value excluding VAT: 325 682.88 RON
           
      137. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 24
           This contract is subject to renewal: no
           
      138. Information about the limits on the number of candidates to be invited:
           
      139. Information about variants:
           Variants will be accepted: no
           
      140. Information about options:
           Options: no
      141. Information about electronic catalogues:
           
           
      142. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      143. Additional information:
           
      144. Title:
           

           Cabazitaxelum 60mg inovativ - fl. 60 mg

           Lot No: 29
           
      145. Additional CPV code(s):
           33652100
           
      146. Place of performance:
           Main site or place of performance:

           FARMACIE

      147. Description of the procurement:
           

           ANTINEOPLAZICE 2

      148. Award criteria:
           
      149. Estimated value:
           Value excluding VAT: 1 001 211.60 RON
           
      150. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 24
           This contract is subject to renewal: no
           
      151. Information about the limits on the number of candidates to be invited:
           
      152. Information about variants:
           Variants will be accepted: no
           
      153. Information about options:
           Options: no
      154. Information about electronic catalogues:
           
           
      155. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      156. Additional information:
           
      157. Title:
           

           Etopozidum -

           Lot No: 15
           
      158. Additional CPV code(s):
           33652100
           
      159. Place of performance:
           Main site or place of performance:

           FARMACIE

      160. Description of the procurement:
           

           ANTINEOPLAZICE

      161. Award criteria:
           
      162. Estimated value:
           Value excluding VAT: 29 568.00 RON
           
      163. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 24
           This contract is subject to renewal: no
           
      164. Information about the limits on the number of candidates to be invited:
           
      165. Information about variants:
           Variants will be accepted: no
           
      166. Information about options:
           Options: no
      167. Information about electronic catalogues:
           
           
      168. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      169. Additional information:
           
      170. Title:
           

           Atezolizumabum - conc.pt.sol .perf.fl 1200mg/20ml

           Lot No: 3
           
      171. Additional CPV code(s):
           33652100
           
      172. Place of performance:
           Main site or place of performance:

           FARMACIE

      173. Description of the procurement:
           

           ANTINEOPLAZICE 2

      174. Award criteria:
           
      175. Estimated value:
           Value excluding VAT: 1 937 775.60 RON
           
      176. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 24
           This contract is subject to renewal: no
           
      177. Information about the limits on the number of candidates to be invited:
           
      178. Information about variants:
           Variants will be accepted: no
           
      179. Information about options:
           Options: no
      180. Information about electronic catalogues:
           
           
      181. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      182. Additional information:
           
      183. Title:
           

           Nivolumabum - conc.pt.sol .perf.fl 10mg/ml 1 fl.din sticlă x 40 mg

           Lot No: 20
           
      184. Additional CPV code(s):
           33652100
           
      185. Place of performance:
           Main site or place of performance:

           FARMACIE

      186. Description of the procurement:
           

           ANTINEOPLAZICE 2

      187. Award criteria:
           
      188. Estimated value:
           Value excluding VAT: 2 034 816.00 RON
           
      189. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 24
           This contract is subject to renewal: no
           
      190. Information about the limits on the number of candidates to be invited:
           
      191. Information about variants:
           Variants will be accepted: no
           
      192. Information about options:
           Options: no
      193. Information about electronic catalogues:
           
           
      194. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      195. Additional information:
           
      196. Title:
           

           Oxaliplatinum - fl. 50 mg

           Lot No: 23
           
      197. Additional CPV code(s):
           33652100
           
      198. Place of performance:
           Main site or place of performance:

           FARMACIE

      199. Description of the procurement:
           

           ANTINEOPLAZICE

      200. Award criteria:
           
      201. Estimated value:
           Value excluding VAT: 58 560.00 RON
           
      202. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 24
           This contract is subject to renewal: no
           
      203. Information about the limits on the number of candidates to be invited:
           
      204. Information about variants:
           Variants will be accepted: no
           
      205. Information about options:
           Options: no
      206. Information about electronic catalogues:
           
           
      207. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      208. Additional information:
           
      209. Title:
           

           Cisplatinum - fl. 50 mg

           Lot No: 9
           
      210. Additional CPV code(s):
           33652100
           
      211. Place of performance:
           Main site or place of performance:

           FARMACIE

      212. Description of the procurement:
           

           ANTINEOPLAZICE 2

      213. Award criteria:
           
      214. Estimated value:
           Value excluding VAT: 4 738.80 RON
           
      215. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 24
           This contract is subject to renewal: no
           
      216. Information about the limits on the number of candidates to be invited:
           
      217. Information about variants:
           Variants will be accepted: no
           
      218. Information about options:
           Options: no
      219. Information about electronic catalogues:
           
           
      220. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      221. Additional information:
           
      222. Title:
           

           Cemiplimabum - 50mg/ml x 7 ml conc. pt. sol. perf. (350 mg cemiplimab)

           Lot No: 6
           
      223. Additional CPV code(s):
           33652100
           
      224. Place of performance:
           Main site or place of performance:

           FARMACIE

      225. Description of the procurement:
           

           ANTINEOPLAZICE 2

      226. Award criteria:
           
      227. Estimated value:
           Value excluding VAT: 1 742 418.24 RON
           
      228. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 24
           This contract is subject to renewal: no
           
      229. Information about the limits on the number of candidates to be invited:
           
      230. Information about variants:
           Variants will be accepted: no
           
      231. Information about options:
           Options: no
      232. Information about electronic catalogues:
           
           
      233. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      234. Additional information:
           
      235. Title:
           

           Gemcitabinum - fl. 2 g

           Lot No: 17
           
      236. Additional CPV code(s):
           33652100
           
      237. Place of performance:
           Main site or place of performance:

           FARMACIE

      238. Description of the procurement:
           

           ANTINEOPLAZICE

      239. Award criteria:
           
      240. Estimated value:
           Value excluding VAT: 41 961.60 RON
           
      241. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 24
           This contract is subject to renewal: no
           
      242. Information about the limits on the number of candidates to be invited:
           
      243. Information about variants:
           Variants will be accepted: no
           
      244. Information about options:
           Options: no
      245. Information about electronic catalogues:
           
           
      246. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      247. Additional information:
           
      248. Title:
           

           Trastuzumabum - fl. 600mg/5ml

           Lot No: 28
           
      249. Additional CPV code(s):
           33652100
           
      250. Place of performance:
           Main site or place of performance:

           FARMACIE

      251. Description of the procurement:
           

           ANTINEOPLAZICE 2

      252. Award criteria:
           
      253. Estimated value:
           Value excluding VAT: 568 683.60 RON
           
      254. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 24
           This contract is subject to renewal: no
           
      255. Information about the limits on the number of candidates to be invited:
           
      256. Information about variants:
           Variants will be accepted: no
           
      257. Information about options:
           Options: no
      258. Information about electronic catalogues:
           
           
      259. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      260. Additional information:
           
      261. Title:
           

           Epirubicinum - sol.inj/perf, fl. 50 mg

           Lot No: 12
           
      262. Additional CPV code(s):
           33652100
           
      263. Place of performance:
           Main site or place of performance:

           FARMACIE

      264. Description of the procurement:
           

           ANTINEOPLAZICE 2

      265. Award criteria:
           
      266. Estimated value:
           Value excluding VAT: 12 578.40 RON
           
      267. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 24
           This contract is subject to renewal: no
           
      268. Information about the limits on the number of candidates to be invited:
           
      269. Information about variants:
           Variants will be accepted: no
           
      270. Information about options:
           Options: no
      271. Information about electronic catalogues:
           
           
      272. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      273. Additional information:
           
      274. Title:
           

           Gemcitabinum - fl. 1 g

           Lot No: 16
           
      275. Additional CPV code(s):
           33652100
           
      276. Place of performance:
           Main site or place of performance:

           FARMACIE

      277. Description of the procurement:
           

           ANTINEOPLAZICE 2

      278. Award criteria:
           
      279. Estimated value:
           Value excluding VAT: 51 834.00 RON
           
      280. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 24
           This contract is subject to renewal: no
           
      281. Information about the limits on the number of candidates to be invited:
           
      282. Information about variants:
           Variants will be accepted: no
           
      283. Information about options:
           Options: no
      284. Information about electronic catalogues:
           
           
      285. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      286. Additional information:
           
      287. Title:
           

           Pembrolizumabum - 1 flac. x 4 ml concentrat (100 mg pembrolizumab)

           Lot No: 26
           
      288. Additional CPV code(s):
           33652100
           
      289. Place of performance:
           Main site or place of performance:

           FARMACIE

      290. Description of the procurement:
           

           ANTINEOPLAZICE 2

      291. Award criteria:
           
      292. Estimated value:
           Value excluding VAT: 1 972 533.36 RON
           
      293. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 24
           This contract is subject to renewal: no
           
      294. Information about the limits on the number of candidates to be invited:
           
      295. Information about variants:
           Variants will be accepted: no
           
      296. Information about options:
           Options: no
      297. Information about electronic catalogues:
           
           
      298. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      299. Additional information:
           
      300. Title:
           

           Paclitaxelum - fl. 260 mg

           Lot No: 25
           
      301. Additional CPV code(s):
           33652100
           
      302. Place of performance:
           Main site or place of performance:

           FARMACIE

      303. Description of the procurement:
           

           ANTINEOPLAZICE 2

      304. Award criteria:
           
      305. Estimated value:
           Value excluding VAT: 426 955.20 RON
           
      306. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 24
           This contract is subject to renewal: no
           
      307. Information about the limits on the number of candidates to be invited:
           
      308. Information about variants:
           Variants will be accepted: no
           
      309. Information about options:
           Options: no
      310. Information about electronic catalogues:
           
           
      311. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      312. Additional information:
           
      313. Title:
           

           Cabazitaxelum biosimilar - Cutie x 1 flacon din sticlă x 1,5 ml concentrat + 1 flacon din sticlă x 4,5 ml solvent (3 ani)

           Lot No: 4
           
      314. Additional CPV code(s):
           33652100
           
      315. Place of performance:
           Main site or place of performance:

           FARMACIE

      316. Description of the procurement:
           

           ANTINEOPLAZICE

      317. Award criteria:
           
      318. Estimated value:
           Value excluding VAT: 1 227 622.80 RON
           
      319. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 24
           This contract is subject to renewal: no
           
      320. Information about the limits on the number of candidates to be invited:
           
      321. Information about variants:
           Variants will be accepted: no
           
      322. Information about options:
           Options: no
      323. Information about electronic catalogues:
           
           
      324. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      325. Additional information:
           
      326. Title:
           

           Ciclophosphamidum - pulb.pt.sol.perf/inj. I.V. 200 mg

           Lot No: 7
           
      327. Additional CPV code(s):
           33652100
           
      328. Place of performance:
           Main site or place of performance:

           FARMACIE

      329. Description of the procurement:
           

           ANTINEOPLAZICE 2

      330. Award criteria:
           
      331. Estimated value:
           Value excluding VAT: 16 311.60 RON
           
      332. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 24
           This contract is subject to renewal: no
           
      333. Information about the limits on the number of candidates to be invited:
           
      334. Information about variants:
           Variants will be accepted: no
           
      335. Information about options:
           Options: no
      336. Information about electronic catalogues:
           
           
      337. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      338. Additional information:
           
      339. Title:
           

           Carboplatinum - fl. 450 mg

           Lot No: 5
           
      340. Additional CPV code(s):
           33652100
           
      341. Place of performance:
           Main site or place of performance:

           FARMACIE

      342. Description of the procurement:
           

           ANTINEOPLAZICE 2

      343. Award criteria:
           
      344. Estimated value:
           Value excluding VAT: 103 142.40 RON
           
      345. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 24
           This contract is subject to renewal: no
           
      346. Information about the limits on the number of candidates to be invited:
           
      347. Information about variants:
           Variants will be accepted: no
           
      348. Information about options:
           Options: no
      349. Information about electronic catalogues:
           
           
      350. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      351. Additional information:
           
      352. Title:
           

           Onko BCG 100 - Vaccin BCG Pulb.+solv.pt.susp. intravezicala

           Lot No: 22
           
      353. Additional CPV code(s):
           33652100
           
      354. Place of performance:
           Main site or place of performance:

           FARMACIE

      355. Description of the procurement:
           

           ANTINEOPLAZICE

      356. Award criteria:
           
      357. Estimated value:
           Value excluding VAT: 463 800.00 RON
           
      358. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 24
           This contract is subject to renewal: no
           
      359. Information about the limits on the number of candidates to be invited:
           
      360. Information about variants:
           Variants will be accepted: no
           
      361. Information about options:
           Options: no
      362. Information about electronic catalogues:
           
           
      363. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      364. Additional information:
           
      365. Title:
           

           Docetaxelum - conc.pt.sol .perf.fl 140 mg

           Lot No: 10
           
      366. Additional CPV code(s):
           33652100
           
      367. Place of performance:
           Main site or place of performance:

           FARMACIE

      368. Description of the procurement:
           

           ANTINEOPLAZICE 2

      369. Award criteria:
           
      370. Estimated value:
           Value excluding VAT: 139 122.00 RON
           
      371. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 24
           This contract is subject to renewal: no
           
      372. Information about the limits on the number of candidates to be invited:
           
      373. Information about variants:
           Variants will be accepted: no
           
      374. Information about options:
           Options: no
      375. Information about electronic catalogues:
           
           
      376. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      377. Additional information:
           
      378. Title:
           

           Oxaliplatinum - fl. 100 mg

           Lot No: 24
           
      379. Additional CPV code(s):
           33652100
           
      380. Place of performance:
           Main site or place of performance:

           FARMACIE

      381. Description of the procurement:
           

           ANTINEOPLAZICE 2

      382. Award criteria:
           
      383. Estimated value:
           Value excluding VAT: 107 532.00 RON
           
      384. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 24
           This contract is subject to renewal: no
           
      385. Information about the limits on the number of candidates to be invited:
           
      386. Information about variants:
           Variants will be accepted: no
           
      387. Information about options:
           Options: no
      388. Information about electronic catalogues:
           
           
      389. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      390. Additional information:
           
3. Section III
   1. Conditions for participation:
      1. Suitability to pursue the professional activity, including requirements relating to enrolment on professional or trade registers:
         List and brief description of conditions:

         Cerința nr. 1. Ofertanții, terții susținători și subcontractanții nu trebuie să se regăsească în situațiile prevăzute la art. 164, 165, 167 din

         Legea nr. 98/2016, respectiv art. 177, 178, 180 din Legea nr. 99/2016. Se va completa DUAE în conformitate cu art. 193 alin. (1) din

         Legea nr. 98/2016, respectiv art. 202 alin. (1) din Legea nr. 99/2016.

         Ofertantii, tertii sustinatori si subcontractantii trebuie sa respecte regulile de evitare a conflictului de interese prevazute la art 59-60

         din Legea nr. 98/2016 privind achizitiile publice; Declaratia conf art.60/Legea 98/2016, va fi prezentata de toti participantii odata cu

         depunerea DUAE. Toate documentele vor fi semnate cu semnatura electronica extinsa conf art.60 alin.(4) din H.G. nr.395/2016

         Documentele justificative care probeaza îndeplinirea celor asumate prin completarea DUAE urmeaza a fi prezentate, LA

         SOLICITAREA AUTORITATII CONTRACTANTE, doar de catre ofertantii clasati pe primele trei locuri în clasamentul intermediar

         întocmit la finalizarea evaluarii ofertelor sunt:

         - certificate constatatoare privind lipsa datoriilor restante, cu privire la plata impozitelor, taxelor sau a contribuțiilor la bugetul

         general consolidat (buget local, buget de stat etc.) la momentul prezentării;

         - cazierul judiciar al operatorului economic și al membrilor organului de administrare, de conducere sau de supraveghere al

         respectivului operator economic, sau a celor ce au putere de reprezentare, de decizie sau de control în cadrul acestuia, așa cum

         rezultă din certificatul constatator emis de ONRC/actul constitutiv;

         - după caz, documente prin care se demonstrează faptul că operatorul economic poate beneficia de derogările prevăzute la art. 166

         alin. (2), art. 167 alin. (2), art. 171 din Legea nr. 98/2016 privind achizițiile publice;

         - alte documente edificatoare, după caz.. În cazul în care în țara de origine sau țara în care este stabilit ofertantul/terțul

         susținător/subcontractantul nu se emit documente de natura celor prevăzute mai sus sau respectivele documente nu vizează toate

         situațiile prevăzute la art. 164, 165 și 167, autoritatea/entitatea contractantă are obligația de a accepta o declarație pe proprie

         răspundere sau, dacă în țara respectivă nu există prevederi legale referitoare la declarația pe propria răspundere, o declarație

         autentică dată în fața unui notar, a unei autorități administrative sau judiciare sau a unei asociații profesionale care are competențe

         în acest sens.

         Totodata, ref. la persoanele responsabile, se va preciza DUAE ca modalitate de indeplinire,

         urmand ca DUAE sa fie prezentata la solicitarea autoritatii contractante doar de catre ofertantii clasati pe primele trei locuri în

         clasamentul intermediar întocmit la finalizarea evaluarii ofertelor

         Cerința nr. 2.

         Persoanele cu funcție de decizie din cadrul autorității/entității contractante cu privire la organizarea, derularea și finalizarea

         procedurii de atribuire sunt: Manager -Dr. Vlad Calin; Director Medical –Prof. Dr. Albu Silviu; Dir. Fin-Contabil Ec. Pasca

         George Cosmin, Dr. Mihailov Anca - Membru , Farm. Pr. Bompa Voichita, Ing. Gaina Cristea Lucia – Sef Serviciu Achiz. Publ. Aproviz,

         Farm. Pr. Antofie Ioan, Serviciul Achizitii PubliceAprovizionare-Ref. Grad Ciprian

         Operatorii economici care depun ofertă trebuie să dovedească o formă de înregistrare în condițiile legii din țara rezidentă, din care

         să reiasă că operatorul economic este legal constituit, că nu se află în niciuna din situațiile de anulare a constituirii, precum și faptul

         că are capacitatea profesională de a realiza activitățile ce fac obiectul contractului de achiziție publică/sectorială. Cerința se aplică

         inclusiv pentru subcontractanți și/sau terți susținători care completează informațiile aferente situației lor la nivelul unui DUAE

         distinct.

         Se va completa DUAE de către operatorii economici participanți la procedura de atribuire a contractului de achiziție

         publică/sectorială cu informațiile solicitate de către autoritatea/entitatea contractantă - informații referitoare la îndeplinirea

         cerințelor privind capacitatea de exercitare a activității profesionale.

         Documentul justificativ care probează îndeplinirea celor asumate prin completarea DUAE, respectiv certificatul constatator emis de

         ONRC, sau în cazul ofertanților persoane juridice/fizice străine, documentele echivalente emise în țara de rezidență, traduse în limba

         română, urmează să fie prezentate, la solicitarea Autorității/entității contractante, doar de către ofertantul clasat pe locul I în

         clasamentul intermediar întocmit la finalizarea evaluării ofertelor.

         În situația în care vor fi executate părți din contract de către subcontractanți, dovada înregistrării și corespondența activităților

         principale/secundare din cadrul acestuia cu obiectul achiziției se va prezenta obligatoriu și de către subcontractanți, pentru partea din contract pe care o vor realiza.

         În procedurile de atribuire a contractelor de achiziție publică/sectorială de produse care cuprind și prestarea de servicii conexe, în

         cazul în care este necesar ca operatorii economici să dețină o autorizație specială, sau să fie membri ai unei anumite organizații

         pentru a putea presta serviciile în cauză în statul de origine, sau să fie înscriși în registre profesionale, autoritatea/entitatea

         contractantă are dreptul de a solicita acestora să demonstreze că dețin o astfel de autorizație/că sunt membri ai unei astfel de

         organizații/sunt înscriși în registre profesionale. Dacă se impune avizarea/atestarea/autorizarea operatorului economic, aceasta

         trebuie să fie în relație directă cu obiectul principal al contractului/relevantă scopului urmărit prin încheierea contractului de achiziție

         publică/sectorială.

         Cerința nr. 3.

         Operatorii economici vor prezenta autorizația de distributie en-gros eliberata de Ministerul Sanatatii prin Agentia Nationala a

         Medicamentului si a Dispozitivelor Medicale, privind autorizarea activitatii de comercializare a medicamentelor,in conformitate cu

         dispozitiile art. 800 alin. (1) din Legea nr. 95/2006 Republicata si ale art. 2 din normele la Ordinul nr. 131/2016 pentru aprobarea

         Normelor privind autorizarea unitatilor de distributie angro de medicamente de uz uman.

         Se va completa DUAE de către operatorii economici participanți la procedura de atribuire a contractului de achiziție

         publică/sectorială cu informațiile solicitate de către autoritatea/entitatea contractantă - informații referitoare la îndeplinirea

         cerințelor privind capacitatea de exercitare a activității profesionale.

         Documentul justificativ care probează îndeplinirea celor asumate prin completarea DUAE, respectiv autorizația de distributie en-gros

         eliberata de Ministerul Sanatatii prin Agentia Nationala a Medicamentului si a Dispozitivelor Medicale, privind autorizarea activitatii

         de comercializare a medicamentelor urmează să fie prezentaa, la solicitarea autorității/entității contractante, doar de către

         ofertantantii clasati pe primele 3 locuri în clasamentul intermediar întocmit la finalizarea evaluării ofertelor.

         Toate documentele vor fi semnate cu semnatura electronica extinsa conf art.60 alin.(4) din H.G. nr.395/2016. Operatorii economici

         straini, vor depune documente echivalente emise in conformitate cu legislatia din tara de rezidenta. Documentele justificative care

         probeaza îndeplinirea celor asumate prin completarea DUAE urmeaza a fi prezentate, LA SOLICITAREA AUTORITATII

         CONTRACTANTE, doar de catre ofertantii clasati pe primele trei locuri în clasamentul intermediar întocmit la finalizarea evaluarii

         ofertelor. ofertantii straini vor prezenta documente echivalente.

      2. Economic and financial standing:
         Selection criteria as stated in the procurement documents
      3. Technical and professional ability:
         Selection criteria as stated in the procurement documents
      4. Information about reserved contracts:
         
   2. Conditions related to the contract:
      1. Information about a particular profession:
         
      2. Information about staff responsible for the performance of the contract:
         
4. Section IV
5. Description:
   1. Type of procedure:
      Open procedure
   2. Information about a framework agreement or a dynamic purchasing system:
      Framework agreement with several operatorsEnvisaged maximum number of participants to the framework agreement: 2
      
   3. Information about reduction of the number of solutions or tenders during negotiation or dialogue:
      
   4. Information about negotiation:
      
   5. Information about electronic auction:
      
   6. Information about the Government Procurement Agreement (GPA):
      The procurement is covered by the Government Procurement Agreement: no
6. Administrative information:
   1. Previous publication concerning this procedure:
      
   2. Time limit for receipt of tenders or requests to participate:
      Date: 2023-10-11
      Local time: 15:00
      
   3. Estimated date of dispatch of invitations to tender or to participate to selected candidates:
      
   4. Languages in which tenders or requests to participate may be submitted:
      RO
   5. Minimum time frame during which the tenderer must maintain the tender:
      Tender must be valid until: 2024-01-11
      (from the date stated for receipt of tender)
      
   6. Conditions for opening of tenders:
      Date: 2023-10-11
      Local time: 15:00
      Place:

      In SEAP

      Information about authorised persons and opening procedure:

      Prof. Dr. Albu Silviu

      Dr. Mihailov Anca

      Farm. Sef. Antofie Ioan

      Ing. Lucia Cristea Graina

      Farm. Pr. Bompa Voichita

      Ref. Grad Ciprian

Источник закупки

Импорт - Экспорт по стране Румыния